|
CN112266400A
|
|
Antitumor compounds
|
|
CN112175027A
|
|
Olive phylline derivative and preparation method and application thereof
|
|
CN112245391A
|
|
Antitumor lipid composition
|
|
CN112245424A
|
|
Application of bisabolane sesquiterpene structural analogue in preparation of anti-coronavirus medicines
|
|
CN112206231A
|
|
Application of matrine derivative in treating non-alcoholic steatohepatitis
|
|
CN111991410A
|
|
Application of oleanolic acid derivatives in preparation of antitumor drugs
|
|
CN111904934A
|
|
Liposome of miRNA185 inhibitor and preparation method thereof
|
|
WO2021051720A1
|
|
Class of anti-human egfr antibody drug conjugate and preparation method and application thereof
|
|
CN111892573A
|
|
Substituted sulfur aromatic heterocyclic compound and preparation method and application thereof
|
|
CN112237584A
|
|
Novel use of compound for preventing and/or treating diseases caused by coronavirus infection
|
|
CN111943946A
|
|
Dihydroquinazinone carboxylic acid compound containing nitrogen heterocyclic segment and application thereof
|
|
CN112063665A
|
|
Preparation method and application of Piericidin (Piericidin)
|
|
CN111773229A
|
|
Application of toosendanin as indoleamine2,3-dioxygenase 1 inhibitor
|
|
CN111675747A
|
|
Antitumor drug and application
|
|
CN111956658A
|
|
Application of miRNA148 cluster as marker for diagnosing and/or treating cognitive disorder-related diseases
|
|
CN111943889A
|
|
Bis-aryl amine compound and preparation method and application thereof
|
|
CN111848558A
|
|
Anti-influenza virus compound derived from Talaromyces, and preparation method and application thereof
|
|
CN111925368A
|
|
Pyrimidone derivatives, preparation method thereof and application thereof in resisting mycobacterium tuberculosis infection
|
|
CN111807952A
|
|
Novel compound participating in lipid metabolism and preparation method thereof
|
|
CN111467366A
|
|
Use of Ebosin for preparing products for preventing and treating psoriasis
|
